Cite
MLA Citation
Jacoline E C Bromberg et al.. “Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.” Lancet oncology, vol. 20, no. 2, 2019, pp. 216–228. http://access.bl.uk/ark:/81055/vdc_100077368073.0x00000a